An oral solid dosage form that is ideal for pediatric and geriatric populations, as well as patients with swallowing difficulties.
Parvulet is an oral solid dosage form that, with the application of water, achieves a texture similar to applesauce
- Easily administered in 30 seconds
- Swallowing aid built into formulation
- Mimics natural swallowing mechanism with no choking hazards
- Available in dispersible granules and tablets
Parvulet addresses multiple challenges
- Ideal for patients with swallowing difficulties
- Dysphagic patients
- Mucositis patients
- Pediatric & geriatric populations
- Allows for high drug loading
- Accurate dosing with every treatment
- Improves patient adherence
- Texture is easy to swallow
- Masked for taste and smell
Parvulet is a patient-friendly format
Studies show 60-79% of the geriatric population and 25-45% of the pediatric will experience difficulty in swallowing.
Oral solid dosage form with final texture similar to that of applesauce:
- Easily administered in 30 seconds
- Swallowing aid built into formulation
- Mimics natural swallowing mechanism with no choking hazards
- Available in dispersible granules and tablets
Speak With An Expert
Nathan Dormer
Director, Drug Product Development
Nathan Dormer, Ph.D., is the Director of Drug Product Development at Adare Pharma Solutions and is responsible for pharmaceutical development activities at Adare’s Lenexa, KS and Philadelphia, PA facilities, where he supports a team of formulation scientists and analysts. He is a pharmaceutical scientist and bioengineer by training, with more than 16 years of experience developing microsphere-based solid oral and parenteral/implantable dosage forms in academic, innovator, and CDMO settings. Dr. Dormer earned his B.S. in Chemical Engineering and his Ph.D. (w/Honors) in Bioengineering from The University of Kansas while receiving NIH-sponsored Pharmaceutical Biotech Training.